Free Trial

Inozyme Pharma (INZY) SEC Filings & 10K Form

Inozyme Pharma logo
$4.00 0.00 (0.00%)
As of 07/1/2025

Recent Inozyme Pharma SEC Filings

DateFilerForm TypeView
07/01/2025
11:15 PM
Inozyme Pharma (Filer)
Form EFFECT
07/01/2025
11:15 PM
Inozyme Pharma (Filer)
Form EFFECT
07/01/2025
8:29 AM
Inozyme Pharma (Filer)
Form POS AM
07/01/2025
8:43 AM
Inozyme Pharma (Filer)
Form S-8 POS
07/01/2025
8:44 AM
Inozyme Pharma (Filer)
Form S-8 POS
07/01/2025
8:45 AM
Inozyme Pharma (Filer)
Form S-8 POS
07/01/2025
8:48 AM
Inozyme Pharma (Filer)
Form S-8 POS
07/01/2025
8:49 AM
Inozyme Pharma (Filer)
Form S-8 POS
07/01/2025
8:51 AM
Inozyme Pharma (Filer)
Form S-8 POS
07/01/2025
8:54 AM
Inozyme Pharma (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
07/01/2025
8:18 AM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-T/A
07/01/2025
8:21 AM
Inozyme Pharma (Subject)
Form SC 14D9/A
07/01/2025
8:25 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025
8:27 AM
Inozyme Pharma (Filer)
Form POS AM
06/20/2025
6:29 PM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2025
6:31 PM
Inozyme Pharma (Filer)
Form DEFA14A
06/17/2025
6:28 AM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-T/A
06/17/2025
5:15 AM
Inozyme Pharma (Subject)
Form SC 14D9/A
06/04/2025
4:09 PM
GLAZER CAPITAL, LLC (Filed by)
Inozyme Pharma (Subject)
Form SCHEDULE 13G
06/04/2025
3:51 PM
Inozyme Pharma (Subject)
Form SC 14D9/A
06/04/2025
3:32 PM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-T/A
06/02/2025
6:35 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
6:14 AM
Inozyme Pharma (Subject)
Form SC 14D9
06/02/2025
5:25 AM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-T
05/30/2025
4:24 PM
Affinity Asset Advisors, LLC (Filed by)
Inozyme Pharma (Subject)
Form SCHEDULE 13G/A
05/19/2025
8:23 PM
Inozyme Pharma (Subject)
Form SC14D9C
05/19/2025
4:22 PM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-C
05/16/2025
8:44 PM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-C
05/16/2025
4:16 PM
BIOMARIN PHARMACEUTICAL INC (Filed by)
Inozyme Pharma (Subject)
Form SC TO-C
05/16/2025
3:40 PM
Inozyme Pharma (Subject)
Form SC14D9C
05/16/2025
7:06 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:33 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
6:36 AM
Inozyme Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
9:28 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Inozyme Pharma (Subject)
Form SCHEDULE 13G/A
04/03/2025
3:27 PM
Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:27 PM
Inozyme Pharma (Issuer)
Subramanian Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:29 PM
Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:24 PM
Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:25 PM
Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
3:26 PM
Inozyme Pharma (Issuer)
Subramanian Sanjay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:17 PM
Inozyme Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
03/10/2025
7:31 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:31 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:32 AM
Inozyme Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2025
7:32 AM
Inozyme Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
12:59 PM
Inozyme Pharma (Subject)
SAMLYN CAPITAL, LLC (Filed by)
Form SCHEDULE 13G/A
01/10/2025
7:06 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:19 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Inozyme Pharma (Subject)
Form SC 13G/A
11/05/2024
7:33 AM
Inozyme Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
7:31 AM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
3:34 PM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Inozyme Pharma (Subject)
Form SC 13G
10/03/2024
7:58 PM
Inozyme Pharma (Issuer)
Treco Douglas A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
7:57 PM
Inozyme Pharma (Issuer)
Winton Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:52 PM
Inozyme Pharma (Filer)
Form 424B5
08/06/2024
3:54 PM
Inozyme Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INZY) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners